Comparison of prevalence, clinical evolution, and vaccination rate against covid 19 in a population of patients diagnosed with dual depression and non-dual depression

Abstract

Introduction

Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen

Objectives

Main: to calculate the prevalence of COVID 19 infection, clinical evolution and vaccination rate in a population of patients diagnosed with dual depression. Secondary: compare these data with those obtained in patients diagnosed with non-dual depression

Methods

Retrospective descriptive study. The study population is made up of patients diagnosed with dual depression and non-dual depression (according to DSM 5 criterion). Infection, admission, death, and vaccination data were obtained from the patient’s medical history

Results

Of the 10 patients diagnosed with dual depression, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 30 patients diagnosed with non-dual depression the prevalence is 3.33% (1/28). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual depression is 30% (3/10) and in the group of non-dual depression is 86.66% (26/30), finding statistically significant differences (P<0.01) between both groups.

Conclusions

In our study the prevalence of COVID 19 infection in patients diagnosed with dual depression is 0% and the vaccination rate is 30%. While in patients with non-dual depression the prevalence is 3.33%, there were no admissions, no deaths and the vaccination rate is 86.66%.

Disclosure

No significant relationships.